Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Niels B. Dalsgaard"'
Autor:
Niels B Dalsgaard, Lærke S Gasbjerg, Laura S Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Knop
Publikováno v:
Endocrine Connections, Vol 13, Iss 7, Pp 1-7 (2024)
Aim: The alpha-glucosidase inhibitor acarbose is approved for the treatment of type 2 diabetes (T2D). It acts in the lumen of the gut by reducing intestinal hydrolysis and absorption of ingested carbohydrates. This reduces postprandial blood glucose
Externí odkaz:
https://doaj.org/article/fc39470700c2487790ef240db845be3a
Autor:
Niels B. Dalsgaard, Lærke S. Gasbjerg, Mads M. Helsted, Laura S. Hansen, Nina L. Hansen, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens J. Holst, Tina Vilsbøll, Filip K. Knop
Publikováno v:
Bone. 170:116687
Autor:
Amalie R. Lanng, Ulrik Becker, Jens J. Holst, Tina Vilsbøll, Joachim Knop, Sigrid Bergmann, Jonatan I. Bagger, Lærke S. Gasbjerg, Lise Gether, Niels B. Dalsgaard, Magnus F. Grøndahl, Signe Foghsgaard, Matthew P. Gillum, Mia Demant, Malte P. Suppli, Nicolai J. Wewer Albrechtsen, Merete J Kønig, Charlotte Strandberg, Henning Grønbæk, Martin L. Thomasen, Filip K. Knop
Publikováno v:
Demant, M, Suppli, M P, Foghsgaard, S, Gether, L, Grøndahl, M F G, Dalsgaard, N B, Bergmann, S S, Lanng, A R, Gasbjerg, L S, Thomasen, M, Bagger, J I, Strandberg, C, Kønig, M J, Grønbæk, H, Becker, U, Wewer Albrechtsen, N J, Holst, J J, Knop, J, Gillum, M P, Vilsbøll, T & Knop, F K 2021, ' Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults ', European Journal of Endocrinology, vol. 185, no. 1, pp. 23-32 . https://doi.org/10.1530/EJE-21-0122
Demant, M, Suppli, M P, Foghsgaard, S, Gether, L, Grøndahl, M F G, Dalsgaard, N B, Bergmann, S S, Lanng, A R, Gasbjerg, L S, Thomasen, M, Bagger, J I, Strandberg, C, Kønig, M J, Grønbæk, H, Becker, U, Holst, J J, Knop, J, Gillum, M P, Vilsbøll, T & Knop, F K 2021, ' Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults ', European Journal of Endocrinology, vol. 185, no. 1, pp. 23-32 . https://doi.org/10.1530/EJE-21-0122
Demant, M, Suppli, M P, Foghsgaard, S, Gether, L, Grøndahl, M F G, Dalsgaard, N B, Bergmann, S S, Lanng, A R, Gasbjerg, L S, Thomasen, M, Bagger, J I, Strandberg, C, Kønig, M J, Grønbæk, H, Becker, U, Holst, J J, Knop, J, Gillum, M P, Vilsbøll, T & Knop, F K 2021, ' Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults ', European Journal of Endocrinology, vol. 185, no. 1, pp. 23-32 . https://doi.org/10.1530/EJE-21-0122
Aims/hypothesis Metabolic effects of intermittent unhealthy lifestyle in young adults are poorly studied. We investigated the gluco-metabolic and hepatic effects of participation in Roskilde Festival (1 week of binge drinking and junk food consumptio
Autor:
Signe Stensen, Tina Vilsbøll, Bolette Hartmann, Jens F. Rehfeld, Filip K. Knop, Niels B. Dalsgaard, Laura S. Hansen, Nina L. Hansen, Lærke S. Gasbjerg, Jens J. Holst
Publikováno v:
European journal of endocrinology. 184(3)
Aims The alpha-glucosidase inhibitor acarbose is believed to reduce plasma glucose by delaying hydrolysis of carbohydrates. Acarbose-induced transfer of carbohydrates to the distal parts of the intestine increases circulating glucagon-like peptide 1
Autor:
Filip K. Knop, Tina Vilsbøll, Laura S. Hansen, Jens J. Holst, Niels B. Dalsgaard, Signe Stensen, Lærke S. Gasbjerg, Nina L. Hansen, Bolette Hartmann
Publikováno v:
Diabetes. 68
The glucose-lowering alpha-glucosidase inhibitor acarbose, is believed to act by delaying digestion and absorption of dietary carbohydrates. It has been shown that acarbose increases circulating glucagon-like peptide 1 (GLP-1). Using the GLP-1 recept
Autor:
Filip K. Knop, Lærke S. Gasbjerg, Tina Vilsbøll, Emilie Bahne, Laura S. Hansen, Andreas Brønden, Jens J. Holst, Pernille H. Sørensen, Niels B. Dalsgaard
Publikováno v:
Diabetes. 67
Metformin is the most widely used plasma glucose-lowering drug for the treatment of type 2 diabetes. It has been shown that metformin increases plasma concentrations of glucagon-like peptide-1 (GLP-1), but it remains unknown whether metformin-induced
Publikováno v:
Dalsgaard, N B, Vilsbøll, T & Knop, F K 2018, ' Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors : A narrative review of head-to-head comparisons ', Diabetes, Obesity and Metabolism, vol. 20, no. 3, pp. 508-519 . https://doi.org/10.1111/dom.13128
BASE-Bielefeld Academic Search Engine
Diabetes, Obesity & Metabolism
BASE-Bielefeld Academic Search Engine
Diabetes, Obesity & Metabolism
Cardiovascular (CV) disease is the leading cause of death and morbidity in patients with type 2 diabetes. Five CV risk factors (blood pressure, resting heart rate, body weight, cholesterol levels and blood glucose) are monitored routinely as safety a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138ce74c879965e8fedc7f245d3a7621
https://curis.ku.dk/portal/da/publications/effects-of-glucagonlike-peptide1-receptor-agonists-on-cardiovascular-risk-factors(c2bcd324-6456-4b79-9436-1d7213949a96).html
https://curis.ku.dk/portal/da/publications/effects-of-glucagonlike-peptide1-receptor-agonists-on-cardiovascular-risk-factors(c2bcd324-6456-4b79-9436-1d7213949a96).html
Publikováno v:
Expert opinion on drug safety. 16(3)
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) constitute a class of drugs for the treatment of type 2 diabetes, and currently, six different GLP-1RAs are approved. Besides improving glycemic control, the GLP-1RAs have other beneficial